Although RKIP’s role has not been directly demonstrated in MASLD models, studies in other liver injury contexts indicate that RKIP-mediated suppression of MAPK and NF-kB pathways exerts protective effects (258, 259). This evidence concerns the gene PEBP1 and metabolic dysfunction-associated steatotic liver disease.